KARI WILLIAMS: Open Payments
NPI 1467418095 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,869 in 170 payments from 17 companies in 2025. Trend: 2023 $2,583 · 2024 $3,109 · 2025 $2,869
Food & beverage: $2,869
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $829 |
| Janssen Biotech, Inc. | 26 | $390 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $324 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $257 |
| Aimmune Therapeutics, Inc. | 10 | $246 |
| Madrigal Pharmaceuticals | 7 | $183 |
| PFIZER INC. | 7 | $138 |
| Regeneron Healthcare Solutions, Inc. | 6 | $138 |
| Phathom Pharmaceuticals, Inc. | 7 | $84 |
| Ardelyx, Inc. | 3 | $81 |
Products named: RINVOQ, TREMFYA, XIFAXAN, ZENPEP, ENTYVIO, REZDIFFRA, DUPIXENT, SKYRIZI.
Industry payments across TN — which companies pay providers there.
